Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02815709 · ClinicalTrials.gov registry record · Phase 3
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy
A Phase 3 study of Acute Pain, sponsored by Trevena.
- Completed
- Registry status
- Phase 3
- Development phase
- 418
- Enrollment target
- 7
- Study locations
NCT02815709: Completed Phase 3 study of Acute Pain, sponsored by Trevena.
NCT02815709 is a Phase 3 study of Acute Pain that has completed, run by Trevena. The registered enrollment target is 418 participants, above the 260-participant average among 50 other Acute Pain trials with a reported enrollment target (61% higher). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02815709, a Phase 3 study of Acute Pain, has completed, sponsored by Trevena.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 418 participants
- Enrollment target
- 7
- Study locations
Study Summary
The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Morphine
- DRUG Oliceridine
Study Locations (7)
California
- Research Site - Anaheim
- Research Site - Pasadena
Texas
- Research Site - Austin
- Research Site - San Antonio
Arizona
- Research Site - Phoenix
Maryland
- Research Site - Pasadena
Utah
- Resarch Site - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 418 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-01 |
| Phase | Phase 3 |
What the finished NCT02815709 record still lists
NCT02815709 is an interventional study that assigns participants to a tested intervention. The registered 418 participants enrollment target is mid-sized for trials with a published cap, above the 260-participant average among 50 other Acute Pain trials with a reported enrollment target (61% higher).
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT02815709 lists 7 locations in 5 states (California, Texas, Arizona).
Frequently Asked Questions
What is clinical trial NCT02815709 about?
NCT02815709 is a clinical study titled "Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy". The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy.
What is the current status of trial NCT02815709?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 418 participants. The study started on 2016-05. Estimated completion is 2017-01.
What conditions does trial NCT02815709 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT02815709?
The interventions under investigation include: Placebo (DRUG), Morphine (DRUG), Oliceridine (DRUG).
Who is sponsoring clinical trial NCT02815709?
This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02815709 being conducted?
This trial has 7 study locations across Arizona, California, Maryland, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02815709's enrollment target sits among peer trials
418 6th of 50 higher than 45 of 50 other Acute Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of XP20B Following Bunionectomy Surgery
COMPLETED · Phase 3
-
Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department
COMPLETED · Phase 3
-
Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion
COMPLETED · Phase 3
-
Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures
COMPLETED · Phase 3
-
A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
COMPLETED · Phase 3
-
Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03135886 · 418 participants · NA
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT06169735 · 417 participants · Phase 4
Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation
- NCT06699901 · 417 participants
Antibiotic Concentrations After MassivE Transfusion Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia